EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: Commentary

William P Martin iD

Kidney360 · 04.06.2026

DOI: 10.34067/kid.0000001279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 04.06.2026. Verfasst von William P Martin. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.

ORCID-Profile: William P Martin

Zitieren

APA

Martin, W. P. (2026). Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: Commentary. Kidney360. https://doi.org/10.34067/kid.0000001279

Vancouver

Martin WP. Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: Commentary. Kidney360. 2026. doi:10.34067/kid.0000001279

BibTeX
@article{Martin2026,
  author = {Martin, William P},
  title = {Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: Commentary},
  journal = {Kidney360},
  year = {2026},
  doi = {10.34067/kid.0000001279}
}
Kostenlos starten →